Citations

Clear

928 citation(s) found for "Rajkumar, S Vincent".

Evolving changes in M-protein (M), quantitative involved immunoglobulin (Ig), and hemoglobin (Hb) to identify patients (pts) with ultra high-risk smoldering multiple myeloma (UHR-SMM).
Ravi, Praful , Kumar, Shaji , Larsen, Jeremy T. , Lacy, Martha Q. , Kapoor, Prashant , Lust, John A., Kyle, Robert A. , Gonsalves, Wilson I. , Buadi, Francis K. , Go, Ronald S. , Dispenzieri, Angela , Gertz, Morie A. , Rajkumar, S. Vincent

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8004-8004

10.1200/jco.2016.34.15_suppl.8004 Get It

Phase 1/2 trial of ixazomib, cyclophosphamide, and dexamethasone for newly diagnosed multiple myeloma (NDMM).
Lacy, Martha Q. , LaPlant, Betsy, Halvorson, Alese E. , Kapoor, Prashant , Hwa, Yi L. , Fonder, Amie , Hayman, Suzanne R. , Stewart, A. Keith, Kumar, Shaji , Bergsagel, P. Leif , Buadi, Francis K. , Leung, Nelson , Go, Ronald S. , Dingli, David , Gertz, Morie A. , Lin, Yi , Dispenzieri, Angela , Fonseca, Rafaël , Mıkhael, Joseph , Rajkumar, S. Vincent

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8002-8002

10.1200/jco.2016.34.15_suppl.8002 Get It

Randomized, open-label, phase 3 study of subcutaneous daratumumab (DARA SC) versus active monitoring in patients (Pts) with high-risk smoldering multiple myeloma (SMM): AQUILA.
Voorhees, Peter M. , Goldschmidt, Hartmut , Bandekar, Rajesh, Kuppens, Steven, Qi, Ming , Rajkumar, S. Vincent , Baker, Ross , Neff, Tobias , Dimopoulos, Meletios Α.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS8062-TPS8062

10.1200/jco.2018.36.15_suppl.tps8062 Get It

Daratumumab-based therapies in patients with AL amyloidosis.
Abeykoon, Jithma P. , Zanwar, Saurabh , Kumar, Shaji , Lacy, Martha Q. , Kourelis, Taxiarchis , Kyle, Robert A. , Kapoor, Prashant , Dispenzieri, Angela , Rajkumar, S. Vincent , Dingli, David , Leung, Nelson , Muchtar, Eli , Gonsalves, Wilson I. , Buadi, Francis K. , Gertz, Morie A.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 8053-8053

10.1200/jco.2018.36.15_suppl.8053 Get It

Duration of complete response (DurCR) impacts overall survival (OS) in multiple myeloma (MM).
Tandon, Nidhi , Lacy, Martha Q. , Fonder, Amie , Hayman, Suzanne R. , Hobbs, Miriam, Warsame, Rahma , Kourelis, Taxiarchis , Hwa, Yi L. , Kapoor, Prashant , Kyle, Robert A. , Kumar, Shaji , Sidana, Surbhi , Dispenzieri, Angela , Gertz, Morie A. , Buadi, Francis K. , Dingli, David , Gonsalves, Wilson I. , Leung, Nelson , Go, Ronald S. , Rajkumar, S. Vincent

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 8045-8045

10.1200/jco.2018.36.15_suppl.8045 Get It

Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy.
Tschautscher, Marcella , Lacy, Martha Q. , Hayman, Suzanne R. , Hwa, Yi L. , Fonder, Amie , Hobbs, Miriam, Zeldenrust, Steven R., Lust, John A., Kapoor, Prashant , Kourelis, Taxiarchis , Warsame, Rahma , Kyle, Robert A. , Kumar, Shaji , Rajkumar, S. Vincent , Buadi, Francis K. , Gertz, Morie A. , Dispenzieri, Angela , Leung, Nelson , Go, Ronald S. , Gonsalves, Wilson I.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 8030-8030

10.1200/jco.2018.36.15_suppl.8030 Get It

Predictors of disease progression in smoldering Waldenström macroglobulinemia.
Zanwar, Saurabh , Abeykoon, Jithma P. , Ansell, Stephen M. , Kumar, Shaji , Lacy, Martha Q. , Nowakowski, Grzegorz S. , Kourelis, Taxiarchis , Kyle, Robert A. , Kapoor, Prashant , Dispenzieri, Angela , Witzig, Thomas E. , Buadi, Francis K. , Dingli, David , Leung, Nelson , Rajkumar, S. Vincent , Go, Ronald S. , Habermann, Thomas M. , Lin, Yi , Gertz, Morie A.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 7571-7571

10.1200/jco.2018.36.15_suppl.7571 Get It

Toward understanding toxicity over time (ToxT) in myeloma cooperative group trials: Feasibility of a novel longitudinal adverse event analysis in ECOG-ACRIN E1A06.
Jacobus, Susanna , Novotny, Paul J. , Stewart, A. Keith, Warsame, Rahma , Midathada, Madhu, Singh, Avina A., O’Brien, Timothy E., MacFarlene, Donald, Grinblatt, David L. , Chanan‐Khan, Asher , Thanarajasingam, Gita , Callander, Natalie S. , Fonseca, Rafaël , Rajkumar, S. Vincent , Dueck, Amylou C.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 6580-6580

10.1200/jco.2018.36.15_suppl.6580 Get It

Utility and prognostic value of 18F-FDG PET/CT scan in patients with newly diagnosed multiple myeloma.
Kumar, Shaji , Kourelis, Taxiarchis , Lacy, Martha Q. , Kapoor, Prashant , Lust, John A., Hayman, Suzanne R. , Hwa, Yi L. , Kyle, Robert A. , Warsame, Rahma , Aljama, Mohammed A. , Sidiqi, M Hasib , Gertz, Morie A. , Rajkumar, S. Vincent , Gonsalves, Wilson I. , Buadi, Francis K. , Dispenzieri, Angela , Dingli, David , Leung, Nelson , Go, Ronald S.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 8023-8023

10.1200/jco.2018.36.15_suppl.8023 Get It